The potential of transapical beating-heart mitral valve repair with neo-chordae

Transapical beating heart mitral valve (MV) repair with an expanded polytetrafluoroethylene (PTFE) chordal implantation device, proofs excellent initial clinical experience in patients suffering from mitral regurgitation (MR) due to degenerative MV disease with isolated posterior leaflet prolapse, as recently reported by Gammie and colleagues (1).